Menu
Log in


Log in

Australian National Clinical Guidelines for Acute Myeloid Leukaemia (AML) Now Available

18 Mar 2025 11:00 AM | Anonymous

Developed by and for the Australian haematology community, these expert-driven, evidence-based guidelines offer:

  • Standardised Care: Enhance patient outcomes with consistent treatment approaches.
  • Access to the Latest Evidence: Support informed clinical decisions.
  • Alignment with Best Practices: Applicable across all clinical settings.

Access the full guidelines here.

This initiative is funded by the Department of Health and Aged Care, facilitated by HSANZ, and supported by the Blood Cancer Taskforce and the Leukaemia Foundation.


Office

145 Macquarie Street
Sydney NSW 2000
hsanz@hsanz.org.au


Follow Us

© 2023 Haematology Society of Australia & New Zealand  All Rights Reserved.

Powered by Wild Apricot Membership Software